Box 36
Container
Contains 19 Results:
Egeberg, Roger O., 1969
File — Box: 36, Folder: 12
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1969
Giambalvo, Joan F., 1967-1971
File — Box: 36, Folder: 13
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1967-1971
Kefauver-Harris Amendments, 1962
File — Box: 36, Folder: 14
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1962
Kilburn, Donald N., 1981-1982
File — Box: 36, Folder: 15
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1981-1982
Ley, Herbert L., Jr., 1968-1970
File — Box: 36, Folder: 16
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1968-1970
Miscellaneous, 1953-1976, 1982
File — Box: 36, Folder: 17
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1953-1976, 1982
Proprietary Association, 1980-1983
File — Box: 36, Folder: 18
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1980-1983
Wolfson, I. David, 1977-1978
File — Box: 36, Folder: 19
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
1977-1978
FDA Background materials, 196[?], 1979
File — Box: 36, Folder: 9
Scope and Contents
From the Series:
The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and...
Dates:
196[?], 1979